Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)

NCT: NCT06569602 · RECRUITING

NCT IDNCT06569602
StatusRECRUITING
Start Date2024-10-01
Completion2033-09-30
SponsorEdwards Lifesciences (INDUSTRY)
First posted
Last updated

Brief Summary

This is a prospective, single-arm, multi-center, real-world study of an the Edwards EVOQUE system.

Frequently Asked Questions

What is Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)?

Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU) is a clinical trial registered under NCT06569602. Current status: RECRUITING.

What is the status of NCT06569602?

The current status of NCT06569602 (Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)) is: RECRUITING.

When did Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU) start?

Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU) started on 2024-10-01.

Related Devices

K251982Edwards MC3 Tricuspid annuloplasty ring (4900)Edwards Lifesciences, LLC PMA P860057replacement Heart-valveEdwards Lifesciences, LLC

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑